124 related articles for article (PubMed ID: 2143598)
1. [Ambulatory multicenter study of Triatec (ramipril). Observations concerning the lessons of the trial for the realization of future trials and for the management of hypertensive patients].
Battaglia C; Gallet M; Carré A
Rev Prat; 1990 Jun; 40(18 Suppl):45-7. PubMed ID: 2143598
[No Abstract] [Full Text] [Related]
2. [The French ambulatory multicenter trial of Triatec: conclusions of the trial].
Le Menn G
Rev Prat; 1990 Jun; 40(18 Suppl):48-50. PubMed ID: 2143599
[TBL] [Abstract][Full Text] [Related]
3. [French multicenter study of Triatec (ramipril) in ambulatory patients: methodology and trial structure].
Vasmant D; Thiéry P
Rev Prat; 1990 Jun; 40(18 Suppl):21-6. PubMed ID: 2143595
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
Guyot D; Lemarié JC
Rev Prat; 1990 Jun; 40(18 Suppl):27-30, 35-8. PubMed ID: 2143596
[TBL] [Abstract][Full Text] [Related]
5. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
[TBL] [Abstract][Full Text] [Related]
6. The effect of ramipril on ambulatory blood pressure: a multicenter trial.
Burris JF
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S131-3. PubMed ID: 1725022
[TBL] [Abstract][Full Text] [Related]
7. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man.
Böhm RO; van Baak MA; Rahn KH
Eur J Clin Pharmacol; 1986; 30(5):541-7. PubMed ID: 3019702
[TBL] [Abstract][Full Text] [Related]
8. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
Bauer B; Lorenz H; Zahlten R
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibitors after myocardial infarction.
Hall AS; Ball SG
Lancet; 1989 Dec 23-30; 2(8678-8679):1527. PubMed ID: 2574802
[No Abstract] [Full Text] [Related]
11. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
Mroczek WJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
[TBL] [Abstract][Full Text] [Related]
13. [Tolerance to Triatec in monotherapy and in combination with Lasilix in a French multicenter study].
Elmalem J
Rev Prat; 1990 Jun; 40(18 Suppl):39-44. PubMed ID: 2143597
[TBL] [Abstract][Full Text] [Related]
14. Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension.
Kaneko Y; Omae T; Yoshinaga K; Iimura O; Inagaki Y; Ishii M; Saruta T; Yamada K; Kumahara Y; Ito K
Am J Cardiol; 1987 Apr; 59(10):86D-91D. PubMed ID: 3034040
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship of ramipril in patients with mild-to-moderate hypertension.
Schnaper HW
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S128-30. PubMed ID: 1725021
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of ramipril.
Ball SG; Robertson JI
Am J Cardiol; 1987 Apr; 59(10):23D-27D. PubMed ID: 3034028
[TBL] [Abstract][Full Text] [Related]
17. First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.
Heber ME; Brigden GS; Caruana MP; Lahiri A; Raftery EB
Am J Cardiol; 1988 Aug; 62(4):239-45. PubMed ID: 2969671
[TBL] [Abstract][Full Text] [Related]
18. Short- and long-term effects of ramipril in hypertension.
de Leeuw PW; Birkenhäger WH
Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
[TBL] [Abstract][Full Text] [Related]
20. Effect of ramipril on 24-hour variability of blood pressure and heart rate in essential hypertension.
Tochikubo O; Asahina S; Kaneko Y
Am J Cardiol; 1987 Apr; 59(10):83D-85D. PubMed ID: 3034039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
